Kevin Winthrop, MD, MPH1, Silvia Delgado, MD2, Mario Habek, MD3, Maria Davydovskaya, PhD4, Brian Ward, MD5, Bruce A. C. Cree, MD, PhD6, Natalia Totolyan, MD7, Linda Mancione, BA8, Roseanne Sullivan, PharmD8, Ronald Zielman, MD, PhD9, Xixi Hu, PhD8, Ayan Das Gupta, MSc10, Xavier Montalban, MD PhD11 and Anne Cross, MD12, (1)Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR, (2)University of Miami Miller School of Medicine, Miami, Florida, USA, FL, (3)University Hospital Center Zagreb, University of Zagreb, School of Medicine, Zagreb, Croatia, Croatia, (4)Moscow state Public Healthcare InszCity Clinical Hospital 24, Moscow, Russia, Russian Federation, (5)Infectious Diseases Division, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, (6)Neurology, UCSF Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, California, USA, San Francisco, CA, (7)First Saint Petersburg State Medical University, St Petersburg, Russian Federation, (8)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (9)Novartis Pharma B.V., Amsterdam, Netherlands, (10)Novartis Healthcare Pvt. Ltd, Hyderabad, India, (11)Department of Neurology-Neuroimmunology, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Hospital Universitario Vall d’Hebron, Barcelona, Spain, (12)Neurology, Washington University School of Medicine, Saint Louis, St. Louis, MO

Laura Balcer, MD, MSCE1, Jeffrey A Cohen, MD2, Fred D. Lublin, MD3, Christopher B. Lock, MD, PhD4, Daniel Pelletier, MD5, Tanuja Chitnis, MD6, Munish Mehra, PhD7, Yael Gothelf, Ph.D.8, Revital Aricha, PhD9, Stacy Lindborg, PhD10, Chaim Lebovits, CEO8 and Ralph Kern, MD, MHSc10, (1)New York University Langone Medical Center, New York, NY, (2)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (3)Corinne Goldsmith Dickinson Center for Multiple Sclerosis, New York, NY, (4)Stanford School of Medicine, Palo Alto, CA, (5)Keck School of Medicine of University of Southern California, Los Angeles, CA, (6)Brigham and Women’s Hospital, Boston, MA, (7)Tigermed, Somerset, NJ, (8)R&D, Brainstorm Cell Therapeutics, Petach Tikva, NY, Israel, (9)R&D, Brainstorm Cell Therapeutics, Petach Tikva, Israel, (10)R&D, Brainstorm Cell Therapeutics, New York, NY

Ludwig Kappos, MD1, Robert J Fox, MD2, Michel Burcklen, PhD3, Mark S Freedman, MSc, MD4, Brian Hennessy, PhD3, Antoine Stos, MSc3, Philippe Linscheid, PhD3, Andrea Vaclavkova, MD3, Hilke Kracker, PhD3, Tatiana Sidorenko, MD, PhD3 and Carlo Pozzilli, MD, PhD5, (1)Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Medicine, Clinical Research and Biomedical Engineering, University Hospital Basel, and University of Basel, Basel, Switzerland, (2)Mellen Center for Treatment and Research in Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (3)Actelion Pharmaceuticals, Part of Janssen Pharmaceutical Companies, Allschwil, Switzerland, (4)Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada, (5)Department of Human Neuroscience, La Sapienza University, Rome, Italy

Mali Coray, PhD1, Andrea Seitzinger, PhD2, Sanjeev Roy, MD3, Mark S Freedman, MSc, MD4, Frederik Barkhof, MD, PhD5,6, Giancarlo Comi, MD7, Nicola De Stefano, MD, PhD8, Ludwig Kappos, PhD9,10, Jens Kuhle, MD, PhD9,11 and Matthias Mehling, PhD1,9,11, (1)Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland, (2)the healthcare business of Merck KGaA, Darmstadt, Germany, (3)Ares Trading S.A, Eysins, Switzerland, (4)Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada, (5)Department of Radiology and Nuclear Medicine, MS Center Amsterdam, Amsterdam, Netherlands, (6)UCL Institute of Neurology, London, United Kingdom, (7)Casa di Cura Privata del Policlinico, Università Vita-Salute San Raffaele, Milan, Italy, (8)Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy, (9)Research Center for Clinical Neuroimmunology and Neuroscience, Basel, Switzerland, (10)Research Center for Clinical Neuroimmunology and Neuroscience, University Hospital Basel, University of Basel, Basel, Switzerland, (11)Neurology Departments of Head, Spine and Neuromedicine, Biomedical Engineering and Clinical Research, University Hospital Basel and University of Basel, Basel, Switzerland

Mark S Freedman, MSc, MD, Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada, Milorad Todorovi?, PhD, the healthcare business of Merck KGaA, Darmstadt, Germany, Zuzana Murgašová, MD, Merck spol. s r.o., an affiliate of Merck KGaA, Darmstadt, Germany, Bratislava, Slovakia and Dominic Jack, PhD, Merck Serono Ltd, Feltham, UK, an affiliate of Merck KGaA, Darmstadt, Germany, Feltham, United Kingdom

Aliya Jaber, BS1, Meera Patel, BS1, Andrew Sylvester, MD1, Mary Yarussi, BSN1, J. Tamar Kalina, PhD2, Jason P Mendoza, PhD2, Robin L Avila, PhD2 and Matthew A Tremblay, MD, Ph.D1, (1)Multiple Sclerosis Comprehensive Care Center, RWJ Barnabas Health, Livingston, NJ, (2)Biogen, Cambridge, MA

Mauricio Rosas-Ballina, MD, PhD1, Annette Wooller, MS2, Robyn Jones, MD3, Andrea Vaclavkova, MD1 and Eva K Havrdova, MD, PhD4, (1)Actelion Pharmaceuticals, Part of Janssen Pharmaceutical Companies, Allschwil, Switzerland, (2)EMEA Medical Affairs, Janssen-Cilag, High Wycombe, United Kingdom, (3)Johnson & Johnson, New Brunswick, NJ, (4)First Medical Faculty, Charles University in Prague, Prague, Czech Republic

Mauricio Rosas-Ballina, MD, PhD1, Annette Wooller, MS2, Verena Walter, MS1, Maria Ait-Tihyaty, PhD3, Andrea Vaclavkova, MD1 and Carlo Pozzilli, MD, PhD4, (1)Actelion Pharmaceuticals, Part of Janssen Pharmaceutical Companies, Allschwil, Switzerland, (2)EMEA Medical Affairs, Janssen-Cilag, High Wycombe, United Kingdom, (3)Global Medical Affairs, Janssen Research & Development, LLC, Titusville, NJ, (4)Department of Human Neuroscience, La Sapienza University, Rome, Italy

Meghan Garabedian, CRNP, MSN, MSCN1, Cortnee Roman, MSN, FNP-BC2, Denise R Bruen, MSN3, Kevin Benny, BS4, Elizabeth Luce, BS, MBA4, Beth Schneider, Senior Research Director4, Shivani Kapadia, PharmD, RPh5, Jason P Mendoza, PhD5, James B Lewin, PharmD5, Mary Zhang, PharmD5 and Sai L Shankar, PhD5, (1)Neurology, Penn Neuroscience Center, Perelmen Center for Advanced Medicine, Philadelphia, PA, (2)Rocky Mountain Multiple Sclerosis Clinic and Research Group, Salt Lake City, UT, (3)University of Virginia Neuroscience, Charlottesville, VA, (4)MyHealthTeam, San Francisco, CA, (5)Biogen, Cambridge, MA

Michelle Maynard, PharmD, BCPS1, Carmen Raschka, RN2, Staley Brod, MD3, Ahmed Z Obeidat, MD, Ph.D.3 and Sam I Hooshmand, DO4, (1)Neurosciences, Froedtert and the Medical College of Wisconsin, Milwaukee, WI, (2)Neurosciences, Froedtert Hospital, Milwaukee, WI, (3)Neurology, Medical College of Wisconsin, Milwaukee, WI, (4)Department of Neurology, Medical College of Wisconsin, Milwaukee, WI

Mitzi J Williams, MD1, Lilyana Amezcua, MD2, Angel Chinea, MD3, Stanley L Cohan, MD, PhD4, Annette Okai, MD5, Darin T Okuda, MD6, Wendy Vargas, MD7, Nicholas Belviso, PhD8, Ivan Bozin, MD9, Xiaotong Jiang, PhD8, James B Lewin, PharmD8, Jennifer Lyons, MD8, Changyu Shen, PhD8, Sarah M England, PhD8 and Nydjie Grimes, MPH, BA10, (1)Joi Life Wellness Group MS Center, Smyrna, GA, (2)Keck School of Medicine, University of Southern California, Los Angeles, CA, (3)San Juan MS Center, Guaynabo, PR, Puerto Rico, (4)Providence Multiple Sclerosis Center, Providence Brain Institute, Portland, OR, (5)North Texas Institute of Neurology and Headache, Plano, TX, (6)Neuroinnovation Program, UT Southwestern Medical Center, Dallas, TX, (7)Columbia University Medical Center, New York, NY, (8)Biogen, Cambridge, MA, (9)Biogen, Baar, Switzerland, (10)Biogen, at the time of this analysis, Cambridge, MA

Mitzi J Williams, MD1, Lilyana Amezcua, MD2, Stanley L Cohan, MD, PhD3, Jeffrey A Cohen, MD4, Silvia R Delgado, MD5, Le H Hua, MD6, Elisabeth B Lucassen, MD7, Xiangyi Meng, PhD7 and James Stankiewicz, MD7, (1)Joi Life Wellness, MS Neurology Center, Smyrna, GA, (2)Keck School of Medicine, University of Southern California, Los Angeles, CA, (3)Providence Multiple Sclerosis Center, Providence Brain Institute, Portland, OR, (4)Cleveland Clinic Mellen Center, Cleveland, OH, (5)Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, (6)Lou Ruvo Center for Brain Health, Las Vegas, NV, (7)Novartis Pharmaceuticals Corporation, East Hanover, NJ

Natalie Abramov, MSc1, Ralph Kern, MD, MHSc2, Haggai Kaspi, PhD1, Stacy Lindborg, PhD2, Yael Gothelf, Ph.D.3, Chaim Lebovits, CEO3 and Revital Aricha, PhD1, (1)R&D, Brainstorm Cell Therapeutics, Petach Tikva, Israel, (2)R&D, Brainstorm Cell Therapeutics, New York, NY, (3)R&D, Brainstorm Cell Therapeutics, Petach Tikva, NY, Israel

Patricia K. Coyle, MD1, Magdaliz Gorritz, MPH2, Rolin L Wade, RPh, MS2, Zifan Zhou, MS2, Subhan Khalid, MS2, Chinmay Deshpande, PhD, BPharm3 and Qiujun Shao, PhD3, (1)Department of Neurology, Stony Brook University, Stony Brook, NY, (2)IQVIA, Plymouth Meeting, PA, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ

Reemal Zaheer, PharmD1, Roma Amin, PharmD, BCACP2, LaTasha Riddick, PharmD, BCACP2, Shuvro Roy, MD3,4, Paulina Kepczynska, PharmD Candidate 20221, Sujin Wolff, PharmD1, Amy Nathanson, PharmD, BCACP2 and Scott D. Newsome, DO, MSCS, FAAN, FANA3,4, (1)Johns Hopkins Medicine (Home Care Group), Baltimore, MD, (2)Johns Hopkins Homecare Group, Baltimore, MD, (3)Department of Neurology, Johns Hopkins University, Baltimore, MD, (4)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD

Regina Berkovich, MD, PhD1, Wing Chow, PharmD, MPH2, Qiujun Shao, PhD2, Magdaliz Gorritz, MPH3, Zifan Zhou, MS3, Hsiu-Ching Chang, PhD3 and Rolin L Wade, RPh, MS3, (1)Neurology Program, Los Angeles County and University of Southern California Medical Center, Los Angeles, CA, (2)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (3)IQVIA, Plymouth Meeting, PA

Sarah Harris, PhD1, Giancarlo Comi, MD2, Bruce A.C. Cree, MD3, Douglas L. Arnold, MD4, Lawrence Steinman, MD5, James K. Sheffield, MD, MBA, MS1, Harry Southworth, PhD6, Rachel Maddux, PhD1, Ludwig Kappos, MD7 and Jeffrey A Cohen, MD8, (1)Bristol Myers Squibb, Princeton, NJ, (2)Vita-Salute San Raffaele University and Casa di Cura del Policlinico, Milan, Italy, (3)Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, (4)NeuroRx Research and Montréal Neurological Institute, McGill University, Montreal, QC, Canada, (5)Beckman Center for Molecular Medicine, Stanford University Medical Center, Stanford, CA, (6)Data Clarity Consulting Ltd., Stockport, United Kingdom, (7)Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), Departments of Head, Spine and Neuromedicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Basel, Switzerland, (8)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH

Sarah Harris, PhD1, Harry Southworth, PhD2, James K. Sheffield, MD1, Rachel Maddux, PhD1 and Jeffrey A. Cohen, MD3, (1)Bristol Myers Squibb, Princeton, NJ, (2)Data Clarity Consulting Ltd., Stockport, United Kingdom, (3)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH

Sean J Pittock, M.D.1, Kerstin Allen, MA2, Yasmin Mashhoon, PhD2 and Marcus Yountz, MD2, (1)Mayo Clinic, Rochester, MN, (2)Alexion Pharmaceuticals, Boston, MA

Shiv Saidha, MBBCh, MD, MRCPI1, Judith Bell, BS2, Sydney Harold, MS2, Jose Marcano Belisario, PhD2, Emma Hawe, MS2, Qiujun Shao, PhD3, Kerri Wyse, Pharm.D., CCRC, CMD3 and Eric M. Maiese, PhD3, (1)Neurology, Johns Hopkins University, Baltimore, MD, (2)RTI Health Solutions, Manchester, United Kingdom, (3)Novartis Pharmaceuticals Corporation, East Hanover, NJ

Silvia R Delgado, MD1, Lilyana Amezcua, MD2, Stanley L Cohan, MD, PhD3, Jeffrey A Cohen, MD4, Le H Hua, MD5, Elisabeth B Lucassen, MD6, Xiangyi Meng, PhD6, Mitzi J Williams, MD7 and James Stankiewicz, MD6, (1)Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, (2)Keck School of Medicine, University of Southern California, Los Angeles, CA, (3)Providence Multiple Sclerosis Center, Providence Brain Institute, Portland, OR, (4)Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, (5)Lou Ruvo Center for Brain Health, Las Vegas, NV, (6)Novartis Pharmaceuticals Corporation, East Hanover, NJ, (7)Joi Life Wellness, MS Neurology Center, Smyrna, GA

Sybil Wray, MD1, Cong Zhu, PhD2, Barry A Singer, MD3, Jelena Drulovic, MD, PhD4, Donald Negroski, MD5, Valencia Hood-Humphrey, MSc2, Sai L Shankar, PhD2, Seth Levin, MD2, Shivani Kapadia, PharmD, RPh2 and Florian Then Bergh, MD6, (1)Hope Neurology, Knoxville, TN, (2)Biogen, Cambridge, MA, (3)The MS Center for Innovations in Care, Missouri Baptist Medical Center, St. Louis, MO, (4)Clinic of Neurology, University of Belgrade, Belgrade, Serbia, (5)MS Center of Sarasota, Sarasota, FL, (6)Department of Neurology, University of Leipzig, Leipzig, Germany

Tyler Kaplan, MD, Neurology, Loyola University Medical Center, Chicago, IL and Jeffrey Kaplan, MD, Kansas City Multiple Sclerosis Center, College Park Specialty Center, Overland Park, KS

Emma McFadden, PhD and Virginia R. Schobel, MSc, Neurology, Spherix Global Insights, Exton, PA

Clara Wan, BA, University of Alabama at Birmingham, Birmingham, AL, Kendall Curtis, BS, University of Pittsburg, Pittsburg, PA, William Meador, MD, Neurology, UAB, Birmingham, AL and John R Rinker, MD, Neurology, University of Alabama at Birmingham, Birmingham, AL

Wen Qin Qiu, BS, University of British Columbia, Vancouver, BC, Canada, Huah Shin Ng, PhD, BPharm, Medicine, University of British Columbia, Vancouver, BC, Canada, Naila Makhani, MD, MPH, Neurology, Yale University School of Medicine, New Haven, CT and Helen Tremlett, PhD, Medicine (Neurology), University of British Columbia, Vancouver, BC, Canada

Katherine L. Cardwell, BHSc1, Taylor Hume, BHSc1, Odessa J. McKenna, MSc1, Afolasade Fakolade, PhD2 and Lara A. Pilutti, PhD3, (1)Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada, (2)School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada, (3)Brain and Mind Research Institute, University of Ottawa, Ottawa, ON, Canada

Björn Meyer, Ph.D.1, Matthias Zenker, M.D.2, Jana Pöttgen, Ph.D.3, Christoph Heesen, M.D.3 and Stefan Gold, Ph.D.4, (1)Research and Development, Gaia Group, Hamburg, Germany, (2)Gaia Group, Hamburg, Germany, (3)Institut für Neuroimmunologie und Multiple Sklerose (INIMS), Zentrum für Molekulare Neurobiologie (ZMNH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany, (4)Klinik für Psychiatrie und Psychotherapie, Charité Universitätsmedizin, Berlin, Germany

Ekaterina Dobryakova, PhD, Kessler Foundation, East Hanover, NJ

Sachi Patil, BA1, Rachel Kenney, PhD2, Lisena Hasanaj, MS1, Binu Joseph, MBBS1, Steven Galetta, MD1 and Laura Balcer, MD MSCE1, (1)Neurology, New York University Grossman School of Medicine, New York, NY, (2)Neurology, Vanderbilt University Medical Center, Nashville, TN

Hoa H. Le, PhD1, Alexander Keenan, MA, MHP1, Michele Cole, PharmD, MS2, Kavita Gandhi, MS2, Nidia Afonso, PharmD2, Lola Adeokun, MPharm2, Eddie Jones, BA3, Mia Berry, BSc3, James Pike, BSc, MPhil3, Nikisha Grant, BSc, MSc3 and Emily Trenholm, BSc3, (1)Johnson & Johnson, Janssen Scientific Affairs, Titusville, NJ, (2)Johnson & Johnson, Research Development, Janssen Pharmaceuticals, Titusville, NJ, (3)Adelphi Real World, Bollington, Cheshire, United Kingdom

Alice E Dias, Dr, Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, Mauricio O Bando, Neuropsychologist, Neurorehabilitation, ABEM – Brazilian Multiple Sclerosis Association, Sao Paulo, Brazil, Juliana AR Telles, MSc, Physiotherapy, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil and Bruna H Sciarinni, Physiotherapist, Physiotherapy, Brazilian Multiple Sclerose Association (ABEM), São Paulo, Brazil

Christine Hampton, MOT, OTR/L, Anna N Berry, PT, DPT and Laura Glazebrook, PT, DPT, Shepherd Center, Atlanta, GA

Mauricio O Bando, Neuropsychologist1, Alice E Dias, Dr2, Juliana AR Telles, MSc3, Demetrios Agourakis, doctor4, Bruna Sciarini, physicaltherapist5, Giovanna Vidigal, physicaltherapist6, André Caetano, physical educator5 and Talita Dias, physicaltherapist6, (1)Neurorehabilitation, ABEM – Brazilian Multiple Sclerosis Association, Sao Paulo, Brazil, (2)Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (3)Physiotherapy, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (4)neurologia, Associação Brasileira de Esclerose Múltipla, São Paulo, Brazil, (5)Associação Brasileira de Esclerose Múltipla, são paulo, Brazil, (6)Universidade de São Paulo, São Paulo, Brazil

Sarah E Talbert, PT, DPT, Rehabilitation Care Line, Cincinnati Veteran’s Affairs Medical Center, Cincinnati, OH and Lauren Yacks, MOT, OTR/L, Rehabilitation Care line, Cincinnati Veteran’s Affairs Medical Center, Cincinnati, OH

Stephanie Teixeira-Poit, PhD, MS1, Paige Dalton, JD2, Alicia Flach, PT, DPT3, Betsy Blake, PharmD, BCPS, FNAP3, Erica Gaskins, PT, DPT, MSCS4, Mona Bostick, RDN, LDN, MSCS5, Suma Shah, MD6, Daniel Webb, PhD1 and Cari Sgroi, PT, DPT, MSCS7, (1)College of Health and Human Sciences, North Carolina A&T State University, Greensboro, NC, (2)National Multiple Sclerosis Society, Greensboro, NC, (3)University of South Carolina, Columbia, SC, (4)NA, Chapel Hill, NC, (5)NA, Greensboro, NC, (6)Department of Neurology, Duke University, Durham, NC, (7)Movement Matters Physical Therapy, Huntersville, NC

Zaenab Dhari, MD1, Ashely Paro, BS2, Rachel Huselid, BA3, Derek Paradis, BS4, Lori Laddaran, BA4, John Garcia Munoz, MPH, MS4, Evan Thomson, BS4, Sara Tabtabai, MD2, Mary Bailey, MD1, Elizabeth S Gromisch, PhD, MSCS5, Jennifer Ruiz, DPT2,4 and group, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Trinity Health of New England, Mount Sinai Rehabilitation hospital, Hartford, CT, (3)Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA, Hartford, CT, (4)Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, USA, North Haven, CT, (5)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT

Alice E Dias, Dr1, Guilherme Olival Sr., doctor2, Helena A Burock, Designer3 and Lucas F Musa, Marketing3, (1)Scientific Research, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil, (2)neurologia, santa casa de misericórdia de são paulo, São Paulo, Brazil, (3)Marketing, Brazilian Multiple Sclerose Association (ABEM), Sao Paulo, Brazil

Andrea Arzt, LCSW, MSCS, Advocacy and Healthcare Access, The National Multiple Sclerosis Society, New York, NY, Sallie E Stephens, BSJ, MS, Advocacy and Healthcare Access, The National Multiple Sclerosis Society, Cincinnati, OH, Evan L. Smith, PhD, Physical Medicine & Rehabilitation, University of Michigan Medicine, Ann Arbor, MI, Kimberly McGuire, PhD, ABPP, MSCS, Psychology & Neuropsychology Department, Kessler Institute for Rehabilitation, West Orange, NJ, Gretchen Shibl, Psy.D., Gretchen Shibl Wellness Psychology, Laguna Hills, CA, Ronnie Hochberg, MS, CRC, LMHC, Private Practice, Queens, NY and Elizabeth Vincent, MSW, LCSW, CBIS, Rehab Without Walls, Houston, TX

Elizabeth S Gromisch, PhD, MSCS1,2,3, Lindsay O Neto, MPH1,4, Jodie K Haselkorn, MD, MPH5,6,7,8 and Aaron P Turner, Ph.D. ABPP (RP)5,6,8, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (3)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (4)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (5)Rehabilitation Care Service, VA Puget Sound Health Care System, Seattle, WA, (6)Department of Rehabilitation Medicine, University of Washington, Seattle, WA, (7)Department of Epidemiology, University of Washington, Seattle, WA, (8)Multiple Sclerosis Center of Excellence West, Veterans Affairs, Seattle, WA